RETRACTION: LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway (Retraction of Vol 13, Pg 8907, 2020)

被引：0
|
作者：
Song, X.
Xu, X.
Ren, X.
Ruan, X.
Wang, Y.
Yao, T. T.
机构：
来源：
ONCOTARGETS AND THERAPY | 2023年 / 16卷
关键词：
D O I：
10.2147/OTT.S418024
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [1] RETRACTED: LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway (Retracted article. See vol. 16, pg. 281, 2023)
    Song, Xue-zhen
    Xu, Xiao-jun
    Ren, Xiao-ning
    Ruan, Xiao-xuan
    Wang, Yi-li
    Yao, Ting-Ting
    ONCOTARGETS AND THERAPY, 2020, 13 : 8907 - 8917
  • [2] RETRACTION: Coronin 3 Promotes the Development of Oncogenic Properties in Glioma Through the Wnt/β-Catenin Signaling Pathway (Retraction of Vol 13, Pg 6661, 2020)
    Wang, M.
    Li, Q.
    Yu, S.
    ONCOTARGETS AND THERAPY, 2024, 17 : 145 - 146
  • [3] RETRACTION: TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
    Zhu, Linan
    Zhang, Xudong
    Fu, Xiaorui
    Li, Zhaoming
    Sun, Zhenchang
    Wu, Jingjing
    Wang, Xinhua
    Wang, Feng
    Li, Xiangke
    Niu, Songtao
    Ding, Mengjie
    Yang, Zhenzhen
    Yang, Wanqiu
    Yin, Meifeng
    Zhang, Lei
    Zhang, Mingzhi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [4] RETRACTION: Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway (Retraction of Vol 12, Pg 5111, 2019)
    Tan, T.
    Chen, J.
    Hu, Y.
    ONCOTARGETS AND THERAPY, 2023, 16 : 275 - 275
  • [5] RETRACTION: Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma (Retraction of Vol 25, Pg 1145, 2020)
    Zhang, Chuantao
    Liu, Jianxiang
    Han, Zhiyi
    Cui, Xiang
    Peng, Deti
    Xing, Yufeng
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (01) : 264 - 264
  • [6] RETRACTION: Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin β-catenin signaling pathway
    Shi, Zhe
    Zhou, Liyuan
    Zhou, Yan
    Jia, Xiaoyan
    Yu, Xiangjun
    An, Xiaohong
    Han, Yanzhen
    BMB REPORTS, 2024, 57 (02)
  • [7] RETRACTION: Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/β-Catenin Signaling Pathway in GC (Retraction of Vol 19, Pg 827, 2020)
    Li, Zheng-Tian
    Zhang, Xu
    Wang, Da-Wei
    Xu, Jun
    Kou, Ke-Jian
    Wang, Zhi-Wei
    Yong, Gong
    Liang, De-Sen
    Sun, Xue-Ying
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 28 : 594 - 594
  • [8] RETRACTION: circPDSS1 Stimulates the Development of Colorectal Cancer via Activating the Wnt/β-Catenin Signaling (Retraction of Vol 13, Pg 6329, 2020)
    Fang, Q.
    Yang, A.
    Dong, A.
    Zhao, L.
    ONCOTARGETS AND THERAPY, 2021, 14 : 4635 - 4635
  • [9] RETRACTION: Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma via Wnt/β-catenin signaling pathway (Retraction of Vol 9, Pg 35473, 2019)
    Jiang, Zhongyu
    Mao, Zhen
    RSC ADVANCES, 2024, 14 (21) : 14514 - 14514
  • [10] RETRACTION: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathway (Retraction of Vol 4, art no 54, 2019)
    Zhang, Rui
    Lin, Hao-Ming
    Broering, Ruth
    Shi, Xiang-de
    Yu, Xian-huan
    Xu, Lei-bo
    Wu, Wen-rui
    Liu, Chao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
12345